Literature DB >> 22771493

Direct cooperation between androgen receptor and E2F1 reveals a common regulation mechanism for androgen-responsive genes in prostate cells.

D M Altintas1, M S Shukla, D Goutte-Gattat, D Angelov, J P Rouault, S Dimitrov, Jacques Samarut.   

Abstract

We have studied the regulation of ATAD2 gene expression by androgens in prostate cells. ATAD2 is a coactivator of the androgen receptor (AR) and the MYC protein. We showed that ATAD2 expression is directly regulated by AR via an AR binding sequence (ARBS) located in the distal enhancer of its regulatory region. The gene is also regulated by the E2F1 transcription factor. Using knockdown and chromatin immunoprecipitation technique approaches, we could demonstrate that AR and E2F1 functionally collaborate and physically interact between each other. From the analysis of chromatin conformation, we conclude that this cooperation results from a chromatin looping over the ATAD2 promoter region between the ARBS and E2F1 binding site in an androgen-dependent manner. Furthermore, we could show that several genes overexpressed in prostate cancer and potentially involved in several aspects of tumor development have an ARBS and an E2F1 binding site in their regulatory regions and exhibit the same mechanism of regulation by both transcription factors as ATAD2.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22771493      PMCID: PMC5416973          DOI: 10.1210/me.2012-1016

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  46 in total

1.  NUBIScan, an in silico approach for prediction of nuclear receptor response elements.

Authors:  Michael Podvinec; Michel R Kaufmann; Christoph Handschin; Urs A Meyer
Journal:  Mol Endocrinol       Date:  2002-06

2.  Induction of human arylamine N-acetyltransferase type I by androgens in human prostate cancer cells.

Authors:  Neville J Butcher; Natasha L Tetlow; Catherine Cheung; Gysell M Broadhurst; Rodney F Minchin
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

3.  Global identification of androgen response elements.

Authors:  Charles E Massie; Ian G Mills
Journal:  Methods Mol Biol       Date:  2011

4.  Conditional deletion of Rb causes early stage prostate cancer.

Authors:  Lisette A Maddison; Brent W Sutherland; Roberto J Barrios; Norman M Greenberg
Journal:  Cancer Res       Date:  2004-09-01       Impact factor: 12.701

5.  Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer.

Authors:  Qianben Wang; Wei Li; Yong Zhang; Xin Yuan; Kexin Xu; Jindan Yu; Zhong Chen; Rameen Beroukhim; Hongyun Wang; Mathieu Lupien; Tao Wu; Meredith M Regan; Clifford A Meyer; Jason S Carroll; Arjun Kumar Manrai; Olli A Jänne; Steven P Balk; Rohit Mehra; Bo Han; Arul M Chinnaiyan; Mark A Rubin; Lawrence True; Michelangelo Fiorentino; Christopher Fiore; Massimo Loda; Philip W Kantoff; X Shirley Liu; Myles Brown
Journal:  Cell       Date:  2009-07-23       Impact factor: 41.582

6.  Androgen regulates Cdc6 transcription through interactions between androgen receptor and E2F transcription factor in prostate cancer cells.

Authors:  Ipsita Mallik; Monica Davila; Tenekua Tapia; Brian Schanen; Ratna Chakrabarti
Journal:  Biochim Biophys Acta       Date:  2008-05-21

7.  Androgen-induced coactivator ANCCA mediates specific androgen receptor signaling in prostate cancer.

Authors:  June X Zou; Linlang Guo; Alexey S Revenko; Clifford G Tepper; Abigael T Gemo; Hsing-Jien Kung; Hong-Wu Chen
Journal:  Cancer Res       Date:  2009-03-24       Impact factor: 12.701

8.  Molecular determinants of resistance to antiandrogen therapy.

Authors:  Charlie D Chen; Derek S Welsbie; Chris Tran; Sung Hee Baek; Randy Chen; Robert Vessella; Michael G Rosenfeld; Charles L Sawyers
Journal:  Nat Med       Date:  2003-12-21       Impact factor: 53.440

9.  DUSP16 is an epigenetically regulated determinant of JNK signalling in Burkitt's lymphoma.

Authors:  S Lee; N Syed; J Taylor; P Smith; B Griffin; M Baens; M Bai; K Bourantas; J Stebbing; K Naresh; M Nelson; M Tuthill; M Bower; E Hatzimichael; T Crook
Journal:  Br J Cancer       Date:  2010-06-15       Impact factor: 7.640

10.  Rapid progression of prostate cancer in men with a BRCA2 mutation.

Authors:  S A Narod; S Neuhausen; G Vichodez; S Armel; H T Lynch; P Ghadirian; S Cummings; O Olopade; D Stoppa-Lyonnet; F Couch; T Wagner; E Warner; W D Foulkes; H Saal; J Weitzel; A Tulman; A Poll; R Nam; P Sun; Jessica Danquah; Susan Domchek; Nadine Tung; Peter Ainsworth; Douglas Horsman; Charmaine Kim-Sing; Christine Maugard; Andrea Eisen; Mary Daly; Wendy McKinnon; Marie Wood; Claudine Isaacs; Dawna Gilchrist; Beth Karlan; Raluca Nedelcu; Wendy Meschino; Judy Garber; Barbara Pasini; Siranoush Manoukian; Christina Bellati
Journal:  Br J Cancer       Date:  2008-06-24       Impact factor: 7.640

View more
  17 in total

Review 1.  Biological function and histone recognition of family IV bromodomain-containing proteins.

Authors:  Jonathan T Lloyd; Karen C Glass
Journal:  J Cell Physiol       Date:  2017-06-13       Impact factor: 6.384

Review 2.  Variable steroid receptor responses: Intrinsically disordered AF1 is the key.

Authors:  S Stoney Simons; Raj Kumar
Journal:  Mol Cell Endocrinol       Date:  2013-06-17       Impact factor: 4.102

3.  Proto-oncogene activity of melanoma antigen-A11 (MAGE-A11) regulates retinoblastoma-related p107 and E2F1 proteins.

Authors:  Shifeng Su; John T Minges; Gail Grossman; Amanda J Blackwelder; James L Mohler; Elizabeth M Wilson
Journal:  J Biol Chem       Date:  2013-07-12       Impact factor: 5.157

4.  Disulfide bridge formation influences ligand recognition by the ATAD2 bromodomain.

Authors:  Jamie C Gay; Brian E Eckenroth; Chiara M Evans; Cassiano Langini; Samuel Carlson; Jonathan T Lloyd; Amedeo Caflisch; Karen C Glass
Journal:  Proteins       Date:  2018-12-27

5.  Chemical synthesis of the ATAD2 bromodomain.

Authors:  Gardner S Creech; Chelsea Paresi; Yue-Ming Li; Samuel J Danishefsky
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-10       Impact factor: 11.205

6.  Coactivator MYST1 regulates nuclear factor-κB and androgen receptor functions during proliferation of prostate cancer cells.

Authors:  Anbalagan Jaganathan; Pratima Chaurasia; Guang-Qian Xiao; Marc Philizaire; Xiang Lv; Shen Yao; Kerry L Burnstein; De-Pei Liu; Alice C Levine; Shiraz Mujtaba
Journal:  Mol Endocrinol       Date:  2014-04-04

7.  The lncRNA SLNCR1 Mediates Melanoma Invasion through a Conserved SRA1-like Region.

Authors:  Karyn Schmidt; Cailin E Joyce; Frank Buquicchio; Adam Brown; Justin Ritz; Robert J Distel; Charles H Yoon; Carl D Novina
Journal:  Cell Rep       Date:  2016-05-19       Impact factor: 9.423

8.  E2F1 regulates testicular descent and controls spermatogenesis by influencing WNT4 signaling.

Authors:  Carolina J Jorgez; Abhishek Seth; Nathan Wilken; Juan C Bournat; Ching H Chen; Dolores J Lamb
Journal:  Development       Date:  2021-01-13       Impact factor: 6.868

9.  Integration of mRNA expression profile, copy number alterations, and microRNA expression levels in breast cancer to improve grade definition.

Authors:  Claudia Cava; Gloria Bertoli; Marilena Ripamonti; Giancarlo Mauri; Italo Zoppis; Pasquale Anthony Della Rosa; Maria Carla Gilardi; Isabella Castiglioni
Journal:  PLoS One       Date:  2014-05-27       Impact factor: 3.240

10.  ATAD2 overexpression links to enrichment of B-MYB-translational signatures and development of aggressive endometrial carcinoma.

Authors:  Camilla Krakstad; Ingvild L Tangen; Erling A Hoivik; Mari K Halle; Anna Berg; Henrica M Werner; Maria B Ræder; Kanthida Kusonmano; June X Zou; Anne M Øyan; Ingunn Stefansson; Jone Trovik; Karl-Henning Kalland; Hong-Wu Chen; Helga B Salvesen
Journal:  Oncotarget       Date:  2015-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.